Multi-center, double-blind, randomized, placebo-controlled, six-arm, parallel-group, dose-finding trial to determine efficacy, safety and tolerability of five different transdermal doses of rotigotine in subjects with idiopathic restless leg syndrome

Trial Profile

Multi-center, double-blind, randomized, placebo-controlled, six-arm, parallel-group, dose-finding trial to determine efficacy, safety and tolerability of five different transdermal doses of rotigotine in subjects with idiopathic restless leg syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 19 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top